Published December 3, 2004 | Version v1
Journal article

Dynamic iodide trapping by tumor cells expressing the thyroidal sodium iodide symporter

  • 1. Molecular Medicine Program, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905 (United States)
  • 2. Division of Endocrinology and Metabolism, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905 (United States)
  • 3. Department of Biochemistry and Molecular Biology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905 (United States)
  • 4. Department of Radiology, Mayo Clinic and Mayo Foundation, 200 First Street SW, Rochester, MN 55905 (United States)

Description

The thyroidal sodium iodide symporter (NIS) in combination with various radioactive isotopes has shown promise as a therapeutic gene in various tumor models. Therapy depends on adequate retention of the isotope in the tumor. We hypothesized that in the absence of iodide organification, isotope trapping is a dynamic process either due to slow efflux or re-uptake of the isotope by cells expressing NIS. Iodide efflux is slower in ARH-77 and K-562 cells expressing NIS compared to a thyroid cell line. Isotope retention half times varied linearly with the number of cells expressing NIS. With sufficient NIS expression, iodide efflux is a zero-order process. Efflux kinetics in the presence or absence of perchlorate also supports the hypothesis that iodide re-uptake occurs and contributes to the retention of the isotope in tumor cells. Iodide organification was insignificant. In vivo studies in tumors composed of mixed cell populations confirmed these observations

Additional details

Identifiers

DOI
10.1016/j.bbrc.2004.09.219;
PII
S0006-291X(04)02244-2;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
325
Journal Issue
1
Journal Page Range
p. 157-166
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2004 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.